Editas Medication to Present at the 41st Annual J.P. Morgan Healthcare Conference CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE)– Editas Medicine, Inc. (Nasdaq: EDIT), a clinical phase genome modifying company, today revealed that the Business’s President and CEO Gilmore O’Neill, M.B., M.M.Sc., will provide at the 41st Annual J.P. Morgan Health Care Conference on Tuesday, January 10, 2023, 4:30 p.m. PT/ 7:30 p.m. ET in San Francisco, CA. A live webcast of the presentation will be offered on the “Investors” area of the Editas Medication website at www.editasmedicine.com.